| Ytd | -45.34% | |
| 1y | -51.49% |
| Open | 2.12 | Prev Close | 2.11 | Low | 2.05 | High | 2.18 | Mkt Cap | 14.06M |
| Vol | 140.60K | Avg Vol | 112.93K | EPS | -4.91 | P/E | N/A | Forward P/E | -0.32 |
| Beta | 1.37 | Short Ratio | 0.71 | Inst. Own | 1.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 1.75 | 200-d Avg | 2.39 | 1yr Est | 70.00 |
SINT News
SINTX TECHNOLOGIES (SINT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism ab
Gainers Anbio Biotechnology (NASDAQ:NNNN) stock moved upwards by 16.9% to $6.49 during Friday's
Third-quarter revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and r
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a company focused
SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(0.75) per share which missed the ana
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advan
Maxim Group analyst Anthony Vendetti reinstates SINTX Technologies (NASDAQ:SINT) with a Buy and a
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced bioma
Shares of SINTX Technologies are trading lower Wednesday afternoon following the company's discl
https://www.sec.gov/ix?doc=/Archives/edgar/data/1269026/000149315226025377/form8-k.htm
HC Wainwright & Co. analyst Brandon Folkes reiterates SINTX Technologies (NASDAQ:SINT) with a
SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(0.70) per share which missed the ana
HC Wainwright & Co. analyst Brandon Folkes initiates coverage on SINTX Technologies (NASDAQ:S
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and l
Recent 2026 Milestones and Execution Progress::Completed first human implant of the SINAPTIC Foot &a
Major clinical milestone marks SINTX's entry into the foot and ankle reconstruction market and a
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and l
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceram
SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(1.19) per share which missed the ana
SALT LAKE CITY, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("
FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceram
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceram
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and l
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceram
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001269026/000149315225012731/form8-k.htm
Shares of SINTX Technologies are trading sharply higher Wednesday morning. The stock is gaining foll
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the comp
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company report